Appleman, D. E., and Evans, H. T. Jr. (1973). “Job 9214: Indexing and least-squares refinement of powder diffraction data,” U.S. Geol. Surv., Comput. Contrib. 20 (Rep. PB2-16188, U.S. Dept. of Commerce, National Technical Information Service, 5825 Port Royal Rd., Springfield, VA 22151).
Bandoli, G., Nicolini, M., and Ongaro, A. (1991). “Powder diffraction data of three 9-amino-1,2,3,4-tetrahydroacridine Alzheimer's disease therapeutics,” Powder Diffr. 6, 196–199.
Bandoli, G., Nicolini, M., and Casellato, U. (1987). “Crystal structure of two tricyclic antidepressant drugs: lofepramine hydrochloride and dothiepin hydrochloride,” J. Cryst. Spectr. Res. 17, 281–293.
Bandoli, G., Nicolini, M., and Tollenaere, J. P. (1984). “Conformation of dibenzo(b,f)heteroepin drugs and the related compounds,” J. Cryst. Spectr. Res. 14, 401–446.
Post, M. L., and Horn, A. S. (1977). “The crystal and molecular structure of the tricyclic antidepressant chlorimipramine hydrochloride,” Acta Cryst. B 33, 2590–2595.
Post, M. L., Kennard, O., and Horn, A. S. (1975). “The tricyclic antidepressants: imipramine hydrochloride,” Acta Cryst. B 31, 1008–1013.
Smith, G., and Snyder, R. (1979). “FN: A criterion for rating powder diffraction patterns and evaluating the reliability of powder pattern indexing,” J. Appl. Crystallogr. 12, 60–65.